Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions. Check out our latest thought leadership pieces below.

A pair of hands hold up a photo of a couple ripped in half around them are rain drops with question marks in them and waves below

Understanding Rare Conditions: The Impact on Relationships

September 26, 2023

Findings from Health Union’s surveys of its rare condition communities show one’s relationships and social life can take significant hits.

NPI Targeting: 3 Reasons It’s a Healthcare Advertiser’s Best Friend

August 14, 2023

A 1:1 relationship with HCPs isn't a guarantee. NPI targeting significantly increases the likelihood that happens.

hands type on keyboard and search for rare disease zebra

Maximizing Consumer Engagement with People Living with Rare Disease

August 2, 2023

Understanding the difficulties people with rare conditions often face can help set the table for the engagement challenges pharma marketers typically face.

Social Health Network's 2023 Social Health Awards winners.

Introducing the 2023 Social Health Awards Winners

July 26, 2023

Meet the groundbreaking group of 2023 award winners who you can connect with through Health Union's Social Health Network!

Let’s Talk About Sex: Why Treating Intimacy As a Clinical Symptom Matters

February 5, 2021

Findings from Health Union’s In America surveys show sex and intimacy can be greatly impacted by a person’s condition, including symptoms and side effects.

The Year of Substance: Finding Success During 2020 and Beyond

January 22, 2021

For Health Union in 2020, substance can be attributed to our mission and core values, a strong people-first culture and the ability to adapt.

5 Ways to Make Your Pharma Marketing More Personal

January 20, 2021

Break through the noise and reach and engage people during their unique health journey with our tips to help personalize your pharma marketing strategies.

The Positive Impact of CFTR Modulators: a Year-Over-Year Comparison

December 22, 2020

Current CFTR modulator usage increased from nearly half of respondents in 2019, when three modulators were approved, to 68% in 2020.

Healthcare Industry Thought Leadership

Contact